This inventor holds 1 USPTO granted patent. Top assignee: Pentapharm Ag. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations in Hematological Assays: The Contributions of Patrizia Maria Gempeler
Introduction
Patrizia Maria Gempeler, an inventive mind based in Aesch, Switzerland, has made significant strides in the field of hematology. With her groundbreaking patent, she has contributed to advancing medical diagnostics, specifically in assessing the blood coagulation potential of body fluids.
Latest Patents
Gempeler holds one notable patent entitled "Hematological assay." This innovative assay involves a method for determining the coagulation potential of a body fluid by reacting it with a specific activator reagent. The reagent comprises a predetermined amount of factor Xa or its equivalent mutant, along with factor Va, or its equivalent mutant, and optionally phospholipids. The assay can be performed using a dry reagent or an aqueous solution, buffered to an optimal pH of 6 to 10. The process may include incubating the sample and using coagulation accelerants, like calcium chloride, to induce coagulation. This innovation provides a means to measure clotting times accurately using optical coagulometers or chromogenic substrates, highlighting the importance of factors derived from Russell's Viper venom.
Career Highlights
Gempeler's impressive career is marked by her dedication to research and development in the medical field. By successfully patenting her hematological assay, she has established herself as a prominent inventor. Her work stands out for its potential applications in improving diagnostic processes, ultimately contributing to enhanced patient care.
Collaborations
In her professional journey, Gempeler has collaborated with Andreas Calatzis, a coworker at Pentapharm AG. Together, their teamwork has fostered innovation, leading to advancements in the medical diagnostics sector. Their combined expertise strengthens the research and development efforts at Pentapharm AG.
Conclusion
Patrizia Maria Gempeler exemplifies the spirit of innovation in medicine through her hematological assay patent. Her contributions not only reflect her skills as an inventor but also underscore the importance of collaboration in advancing healthcare technology. As medical diagnostics continue to evolve, Gempeler's work holds promise for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile